Mirion Technologies Inc (MEX:MIR)
MXN 321.32 (0%) Market Cap: 78.61 Bil Enterprise Value: 94.01 Bil PE Ratio: 181.44 PB Ratio: 2.17 GF Score: 33/100

Q2 2025 Mirion Technologies Inc Earnings Call Transcript

Aug 01, 2025 / 02:00PM GMT
Release Date Price: MXN375.7

Key Points

Positve
  • Mirion Technologies Inc (MIR) reported a 7.6% increase in total revenue for Q2 2025 compared to the same period last year, with organic revenue growth of 5.4%.
  • The company successfully completed a $400 million convertible note offering and refinanced its term loan, improving its capital structure and reducing the total cost of capital.
  • Mirion Technologies Inc (MIR) raised its 2025 guidance for total revenue growth, adjusted EBITDA, adjusted free cash flow, and adjusted EPS, reflecting a positive outlook for the second half of the year.
  • The acquisition of SURTAC, a provider of regulatory compliance solutions, is expected to enhance growth in the nuclear power sector and expand Mirion Technologies Inc (MIR)'s presence in the North American energy markets.
  • The company is experiencing growing momentum in the nuclear power sector, with significant opportunities in modernization upgrades, expanding nuclear capacity, and extending operating lifetimes of nuclear reactors.
Negative
  • Nuclear and safety segment orders were lower in Q2 2025 compared to the previous year, due to a tough comparison with a strong Q2 2024.
  • The company faced non-recurring cost items in its nuclear and safety segment, including FX-related transactional headwinds in France and project cost increases in the UK, which impacted margins.
  • Mirion Technologies Inc (MIR) slightly lowered its organic revenue growth expectations for 2025 due to US government budgetary headwinds affecting its labs and research business.
  • The company acknowledged potential risks of timing slippage in government-related and new project orders, which could impact the order pipeline.
  • There is ongoing uncertainty in the medical segment due to budgetary dynamics and potential impacts from changes in Medicaid and Medicare reimbursements.
Operator

Greetings and welcome to the Marion Technologies 2nd quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance, please press 0 on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce Eric Lin, Vice President of Investor Relations. Please go ahead.

Eric Lin
Mirion Technologies Inc - Vice President of Investor Relations

Thank you, Stacey. Good morning and welcome to Marion 2nd quarter 2025 earnings conference call.

Joining me this morning are Marion's Chairman and CEO Tom Logan, and Marion's CFO and medical group President, Brian Schopfer.

Before we begin today's prepared remarks, allow me to remind you that comments made during this call will include forward-looking statements, and actual results may differ materially from those projected in the forward-looking statements.

The factors that could cause actual results to differ are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot